Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.
2.

Activation of natural killer cells by Bacillus Calmette-Guérin.

Brandau S, Böhle A.

Eur Urol. 2001 May;39(5):518-24.

PMID:
11464031
3.

On the mode of action of intravesical bacillus Calmette-Guérin: in vitro characterization of BCG-activated killer cells.

Böhle A, Thanhäuser A, Ulmer AJ, Mattern T, Ernst M, Flad HD, Jocham D.

Urol Res. 1994;22(3):185-90.

PMID:
7527607
4.

Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.

Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, Jocham D, Flad HD, Böhle A.

Clin Cancer Res. 2000 Sep;6(9):3729-38.

5.

Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.

Suttmann H, Jacobsen M, Reiss K, Jocham D, Böhle A, Brandau S.

J Urol. 2004 Oct;172(4 Pt 1):1490-5.

PMID:
15371877
6.

NK cells are essential for effective BCG immunotherapy.

Brandau S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, Zhao X, Jocham D, Ratliff TL, Böhle A.

Int J Cancer. 2001 Jun 1;92(5):697-702.

7.

In vitro generation of bacillus Calmette-Guérin-activated killer cells.

Brandau S, Böhle A, Thanhäuser A, Ernst M, Mattern T, Ulmer AJ, Flad HD.

Clin Infect Dis. 2000 Sep;31 Suppl 3:S94-S100.

PMID:
11010832
8.

Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.

Liu W, O'Donnell MA, Chen X, Han R, Luo Y.

Cancer Immunol Immunother. 2009 Oct;58(10):1647-55. doi: 10.1007/s00262-009-0673-z. Epub 2009 Feb 13.

PMID:
19214503
9.

Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.

Secanella-Fandos S, Noguera-Ortega E, Olivares F, Luquin M, Julián E.

J Urol. 2014 May;191(5):1422-8. doi: 10.1016/j.juro.2013.12.002. Epub 2013 Dec 10.

PMID:
24333111
10.

The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.

Yutkin V, Pode D, Pikarsky E, Mandelboim O.

J Urol. 2007 Dec;178(6):2660-4. Epub 2007 Oct 22.

PMID:
17945285
12.

Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.

Chen F, Zhang G, Cao Y, Payne R, See WA.

J Urol. 2007 Nov;178(5):2166-70. Epub 2007 Sep 17.

PMID:
17870116
13.

Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.

Gandhi NM, Morales A, Lamm DL.

BJU Int. 2013 Aug;112(3):288-97. doi: 10.1111/j.1464-410X.2012.11754.x. Epub 2013 Mar 20. Review.

14.

Growth inhibition of HeLa cell by internalization of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) Tokyo.

Kitamura A, Mastumoto S, Asahina I.

Cancer Cell Int. 2009 Dec 2;9:30. doi: 10.1186/1475-2867-9-30.

15.

Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines.

Bourgo RJ, Braden WA, Wells SI, Knudsen ES.

Mol Carcinog. 2009 Jan;48(1):45-55. doi: 10.1002/mc.20456.

16.

The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.

Gontero P, Oderda M, Mehnert A, Gurioli A, Marson F, Lucca I, Rink M, Schmid M, Kluth LA, Pappagallo G, Sogni F, Sanguedolce F, Schiavina R, Martorana G, Shariat SF, Chun F.

J Urol. 2013 Sep;190(3):857-62. doi: 10.1016/j.juro.2013.03.097. Epub 2013 Mar 29.

PMID:
23545101
17.

Retinoblastoma protein expression predicts response to bacillus Calmette-Guérin immunotherapy in patients with T1G3 bladder cancer.

Cormio L, Tolve I, Annese P, Saracino A, Zamparese R, Sanguedolce F, Bufo P, Battaglia M, Selvaggi FP, Carrieri G.

Urol Oncol. 2010 May-Jun;28(3):285-9. doi: 10.1016/j.urolonc.2008.08.003. Epub 2008 Oct 31.

PMID:
18976938
18.

The role of LFA-1 in the lysis of bladder cancer cells by bacillus Calmette-Guérin and interleukin 2-activated killer cells.

Suttmann H, Jocham D, Böhle A, Brandau S.

Urol Res. 2002 Sep;30(4):233-9. Epub 2002 Jul 5.

PMID:
12202941
19.

Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer.

Ayari C, Besançon M, Bergeron A, LaRue H, Bussières V, Fradet Y.

Cancer Immunol Immunother. 2016 Feb;65(2):223-34. doi: 10.1007/s00262-015-1789-y. Epub 2016 Jan 12.

PMID:
26759009
20.

Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.

Naoe M, Ogawa Y, Takeshita K, Morita J, Iwamoto S, Miyazaki A, Yoshida H.

Int J Urol. 2007 Jun;14(6):532-8; discussion 538.

Supplemental Content

Support Center